Cytogenetics, Not Just Previous Therapy, Determines the Course of Therapy-Related Myeloid Neoplasms
- 1 July 2012
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (19) , 2300-2302
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid NeoplasmsJournal of Clinical Oncology, 2012
- Therapy-Related Myeloid Neoplasms (t-MN) in 71 Patients Following Radiation Therapy (RT) Only,Blood, 2011
- Assessing the risk of second malignancies after modern radiotherapyNature Reviews Cancer, 2011
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLBlood, 2011
- Cytogenetic and genetic pathways in therapy-related acute myeloid leukemiaChemico-Biological Interactions, 2010
- Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibilityBlood, 2009
- Therapy-related myeloid neoplasmsHaematologica, 2009
- Therapy-Related Myeloid LeukemiaSeminars in Oncology, 2008
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesBlood, 2003
- International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview reportGenes, Chromosomes and Cancer, 2002